Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.44 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ITGB3 | P05106 | 2/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 2/20 | 0.37 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13210852 | 0.90 | HSD17B10 (0.41) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT | |
| SCHEMBL2910415 | 0.87 | CHRM5 (0.40) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT | |
| SCHEMBL2909901 | 0.87 | HSD17B10 (0.39) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT | |
| Tetraxetan SCHEMBL4293643 | 0.85 | HSD17B10 (0.61) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT | |
| SCHEMBL321989 | 0.83 | HSD17B10 (0.64) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT | |
| Tetraxetan SCHEMBL18018 | 0.83 | HSD17B10 (0.64) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT | |
| Tetraxetan SCHEMBL2635294 | 0.83 | HSD17B10 (0.64) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT | |
| SCHEMBL6848102 | 0.83 | HSD17B10 (0.64) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT | |
| SCHEMBL173508 | 0.83 | HSD17B10 (0.64) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT | |
| Tetraxetan SCHEMBL2017956 | 0.83 | HSD17B10 (0.64) | HSD17B10S1PR1SLC6A9ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1045838-B1 | 1,4,7,10-TETRAAZACYCLODODECANE-1,4-DIACETIC ACID | BRACCO IMAGING SPA (IT) | 2007-02-28 | — | — | EP | claimed |
| EP-1047677-B1 | Process for the preparation of derivatives of 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid | BRACCO SPA (IT) | 2005-07-20 | — | — | EP | claimed |
| US-6417354-B1 | ALKYLATION USING HALOACETIC ACID; BASIC HYDROLYSIS UNDER HIGH PRESSURE; DECYCLIZATION, RING EXPANSION, SALT FORMATION, QUATERNIZATION | DIBRA S.P.A. (IT) | 2002-07-09 | — | — | US | claimed |
| US-6342597-B1 | CONDENSATION REACTION TRIETHYLENETETRAMINE WITH GLYOXAL TO CYCLIZE; OXIDATION, ALKYLATION, HYDROLYSIS, QUATERNIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING | DIBRA S.P.A. (IT) | 2002-01-29 | — | — | US | claimed |
| EP-1045838-A1 | 1,4,7,10-TETRAAZACYCLODODECANE-1,4-DIACETIC ACID | BRACCO S.p.A. (IT) | 2000-10-25 | — | — | EP | claimed |
| WO-1999035134-A1 | 1,4,7,10-TETRAAZACYCLODODECANE-1,4-DIACETIC ACID | BRACCO S.P.A. (IT) | 1999-07-15 | — | — | WO | claimed |
| US-20210380542-A1 | NOVEL PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELANT 2,2',2''-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRA AZACYCLODODECANE-1,4,7-TRIYL) TRIACETIC ACID AND IT'S COMPLEXES WITH PARAMAGNETIC METAL IONS | BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. (IN) | 2021-12-09 | — | — | US | disclosed |
| EP-1045838-B1 | 1,4,7,10-TETRAAZACYCLODODECANE-1,4-DIACETIC ACID | BRACCO IMAGING SPA (IT) | 2007-02-28 | — | — | EP | disclosed |
| EP-1045838-B1 | 1,4,7,10-TETRAAZACYCLODODECANE-1,4-DIACETIC ACID | BRACCO IMAGING SPA (IT) | 2007-02-28 | — | — | EP | disclosed |
| EP-1602649-A2 | 1,4,7,10-TETRAAZACYCLODODECANE-1,4-DIACETIC ACID DERIVATIVES AS CHELATING AGENTS | BRACCO S.p.A. (IT) | 2005-12-07 | — | — | EP | disclosed |
| EP-1047677-B1 | Process for the preparation of derivatives of 1,4,7,10-tetraazacyclododecane-1,4-diacetic acid | BRACCO SPA (IT) | 2005-07-20 | — | — | EP | disclosed |
| US-6417354-B1 | ALKYLATION USING HALOACETIC ACID; BASIC HYDROLYSIS UNDER HIGH PRESSURE; DECYCLIZATION, RING EXPANSION, SALT FORMATION, QUATERNIZATION | DIBRA S.P.A. (IT) | 2002-07-09 | — | — | US | disclosed |
| US-6342597-B1 | CONDENSATION REACTION TRIETHYLENETETRAMINE WITH GLYOXAL TO CYCLIZE; OXIDATION, ALKYLATION, HYDROLYSIS, QUATERNIZATION; NUCLEAR MAGNETIC RESONANCE IMAGING | DIBRA S.P.A. (IT) | 2002-01-29 | — | — | US | disclosed |
| EP-1045838-A1 | 1,4,7,10-TETRAAZACYCLODODECANE-1,4-DIACETIC ACID | BRACCO S.p.A. (IT) | 2000-10-25 | — | — | EP | disclosed |
| WO-1999035134-A1 | 1,4,7,10-TETRAAZACYCLODODECANE-1,4-DIACETIC ACID | BRACCO S.P.A. (IT) | 1999-07-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210380542-A1 | NOVEL PROCESS FOR THE PREPARATION OF MACROCYCLIC CHELANT 2,2',2''-(10-(2-HYDROXYPROPYL)-1,4,7,10-TETRA AZACYCLODODECANE-1,4,7-TRIYL) TRIACETIC ACID AND IT'S COMPLEXES WITH PARAMAGNETIC METAL IONS | TMCO1, ITPR1, ITPR2 | HSD17B10 1825/4885S1PR1 779/4885SLC6A9 488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.